Publications

2020

  1. Rahimzadeh G, Resch G, Rezai MS, Nemati Hevelaee E. Characterization and Lytic Activity of Isolated Escherichia coli Bacteriophages against Escherichia coli in vitro. Iran J Med Sci. 2020 Jul;45(4):298-303. doi: 10.30476/ijms.2019.45420.

2019

  1. Testa S, Berger S, Piccardi P, Oechslin F, Resch G, Mitri S. Spatial structure affects phage efficacy in infecting dual-strain biofilms of Pseudomonas aeruginosa. Commun Biol. 2019 Nov 4;2:405. doi: 10.1038/s42003-019-0633-x. eCollection 2019.

  2. Cameron DR, Ramette A, Prazak J, Entenza J, Haenggi M, Que YA, Resch G. Draft Genome Sequence of Methicillin-Resistant Staphylococcus aureus Strain AW7, Isolated from a Patient with Bacteremia. Microbiol Resour Announc. 2019 Oct 3;8(40):e00806-19. doi: 10.1128/MRA.00806-19.

  3. Prazak J, Iten M, Cameron DR, Save J, Grandgirard D, Resch G, Goepfert C, Leib SL, Takala J, Jakob SM, Que YA, Haenggi M. Bacteriophages Improve Outcome in Experimental Staphylococcus Aureus Ventilator Associated Pneumonia.  Am J Respir Crit Care Med. 2019 Jul 1. doi: 10.1164/rccm.201812-2372OC.

  4. Leshkasheli L, Kutateladze M, Balarjishvili N, Bolkvadze D, Save J, Oechslin F, Que Y-A, Resch GEfficacy of Newly Isolated and Highly Potent Bacteriophages in a Mouse Model of XDRAB Bacteremia. J Global Antimicrob Resist. https://doi.org/10.1016/j.jgar.2019.05.005.

  5. Desgranges F, Bochud PY, Resch G. Customised infectiology – Phage therapy: from theory to clinical evidenceRev Med Suisse. 2019 Apr 10;15(646):771-775

  6. Leuenberger A, Sartori C, Boss R, Resch G, Oechslin F, Steiner A, Moreillon P, Graber HU. Genotypes of Staphylococcus aureus: On-farm epidemiology and the consequences for prevention of intramammary infectionsJ Dairy Sci. 2019 Feb 6. pii: S0022-0302(19)30117-1. doi: 10.3168/jds.2018-15181.

  7. C. EssohJ.P. VernadetG. VergnaudA. CoulibalyA. Kakou-N’DoubaA. S.-P. N’GuettaG. ReschC. Pourcel. Complete Genome Sequences of Five Acinetobacter baumannii Phages from Abidjan, Côte d’Ivoire. Microbiol Resour Announc 

2018

  1. Leite DMC, Brochet X, Resch G, Que YA, Neves A, Peña-Reyes C. Computational prediction of inter-species relationships through omics data analysis and machine learningBMC Bioinformatics. 2018 Nov 20;19(Suppl 14):420. doi: 10.1186/s12859-018-2388-7.

  2. Jault P., Leclerc T., Jennes S., Pirnay J.P., Que Y.A., Resch G., Rousseau AF., Ravat F., Carsin H., Le Floch R., Schaal J.V., Soler C., Fevre C., Arnaud I., Bretaudeau L., Gabard J. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn) : a randomised, controlled, double-blind phase 1/2 trial. The Lancet Infectious Diseases. http://dx.doi.org/10.1016/ S1473-3099(18)30482-1.

  3. Vacheron J, Kupferschmied P, Resch G, Keel C. Genome Sequence of the Pseudomonas protegens Phage ΦGP100. Genome Announc. 2018 Jun 21;6(25). pii: e00261-18. doi: 10.1128/genomeA.00261-18.

  4. Rohde C, Resch G, Pirnay JP, Blasdel BG, Debarbieux L, Gelman D, Górski A, Hazan R, Huys I, Kakabadze E, Łobocka M, Maestri A, Almeida GMF, Makalatia K, Malik DJ, Mašlaňová I, Merabishvili M, Pantucek R, Rose T, Štveráková D, Van Raemdonck H, Verbeken G, Chanishvili N. Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains. Viruses. 2018 Apr 5;10(4). pii: E178. doi: 10.3390/v10040178.

  5. Larpin Y, Oechslin F, Moreillon P, Resch G, Entenza JM, Mancini S. In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteriaPLoS One. 2018 Feb 6;13(2):e0192507. doi: 10.1371/journal.pone.0192507.

2017

  1. Carvalho Leite, D. M., Brochet, X., Resch, G., Que, Y.-A., Neves, A., & Peña-Reyes, C. (2017). Computational Prediction of Host-Pathogen Interactions Through Omics Data Analysis and Machine Learning. In Bioinformatics and Biomedical Engineering (pp. 360–371). Springer International Publishing. https://doi.org/10.1007/978-3-319-56154-7_33.
  2. Oechslin F, Piccardi P, Mancini S, Gabard J, Moreillon P, Entenza JM, Resch G*, Que YA*. Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence. J Infect Dis. 2017 Mar 1;215(5):703-712. doi: 10.1093/infdis/jiw632. *equal contribution.
  3. Shlezinger M, Houri-Haddad Y, Coppenhagen-Glazer S, Resch G, Que YA, Beyth S, Dorfman E, Hazan R, Beyth N. Phage therapy: A new horizon in the antibacterial treatment of oral pathogens. Curr Top Med Chem. 2017;17(10):1199-1211. doi: 10.2174/1568026616666160930145649. Review.

2016

  1. Morales M, Sentchilo V, Bertelli C, Komljenovic A, Kryuchkova-Mostacci N, Bourdilloud A, Linke B, Goesmann A, Harshman K, Segers F, Delapierre F, Fiorucci D, Seppey M, Trofimenco E, Berra P, El Taher A, Loiseau C, Roggero D, Sulfiotti M, Etienne A, Ruiz Buendia G, Pillard L, Escoriza A, Moritz R, Schneider C, Alfonso E, Ben Jeddou F, Selmoni O, Resch G, Greub G, Emery O, Dubey M, Pillonel T, Robinson-Rechavi M, van der Meer JR. The Genome of the Toluene-Degrading Pseudomonas veronii Strain 1YdBTEX2 and Its Differential Gene Expression in Contaminated Sand. PLoS One. 2016 Nov 3;11(11):e0165850.

  2. Diene SM, François P, Zbinden A, Entenza JM, Resch GComparative Genomics Analysis of Streptococcus tigurinus Strains Identifies Genetic Elements Specifically and Uniquely Present in  Highly Virulent Strains. PLoS One. 2016 Aug 9;11(8):e0160554.

  3. Pirnay JP, McCallin S, De Vos D, Alavidze Z, Aminov R, Bardiau M, Bretaudeau L, Caplin J, Chanishvili N, Aidan C, Cooper J, Friman VP, Hoyle N, Karanadze N, Kurtboke I, Kutateladze M, Merabishvili M, Mgaloblishvili G, Nadareishvili L, Nikolaishvili N, Nizharadze D, Roman P, Resch G, Rohde C, Shulaia T, Tediashvili M, Ujmajuridze A, Sybesma W. Silk Road to the Acceptance and Re-implementation of Bacteriophage Therapy. Biotechnol. J. 2016 Mar. 23. Ahead of print.

2015

  1. Pirnay JP, Blasdel BG, Bretaudeau L, Buckling A, Chanishvili N, Clark JR, Corte-Real S, Debarbieux L, Dublanchet A, De Vos D, Gabard J, Garcia M, Goderdzishvili M, Górski A, Hardcastle J, Huys I, Kutter E, Lavigne R, Merabishvili M, Olchawa E, Parikka KJ, Patey O, Pouilot F, Resch G, Rohde C, Scheres J, Skurnik M, Vaneechoutte M, Van Parys L, Verbeken G, Zizi M, Van den Eede G. Quality and Safety Requirements for Sustainable Phage Therapy Products. Pharm. Res. 2015 Jul;32(7):2173-9.

2013

  1. Oechslin F, Daraspe J, Giddey M, Moreillon P, Resch G. In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae. Antimicrob. Agents Chemother. 2013 Dec; 57(12):6276-83.
  2. Vouillamoz J, Entenza JM, Giddey M, Fischetti VA, Moreillon P, Resch G. Bactericidal Synergism Between Daptomycin and the Phage Lysin Cpl-1 in a Mouse Model of Pneumococcal Bacteremia. Int. J. Antimicrob. Agents. 2013 Nov; 42(5):416-21.
  3. Resch G, François P, Morisset D, Stojanov M, Bonetti EJ, Schrenzel J, Sakwinska O, Moreillon P. Human-to-bovine jump of Staphylococcus aureus CC8 is associated with the loss of a β-hemolysin converting prophage and the acquisition of a new staphylococcal cassette chromosome. PLoS One. 2013; 8(3):e58187.

2012

  1. Ythier M, Resch G, Waridel P, Panchaud A, Gfeller A, Majcherczyk P, Quadroni M, Moreillon P. Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypesMol Cell Proteomics. 2012 Nov;11(11):1123-39.

2011

  1. Resch G, Moreillon P, Fischetti VA. 2011. A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance. Int. J. Antimicrob. Agents. 2011 Dec; 38(6):516-21.
  2. Resch G, Moreillon P, Fischetti VA. PEGylating a bacteriophage endolysin inhibits its bactericidal activityAMB Express. 2011 Oct 7;1:29.

2004

  1. Resch G, Kulik EM, Dietrich FS, Meyer J. Complete genomic nucleotide sequence of the temperate bacteriophage AaPhi23 of Actinobacillus actinomycetemcomitansJ Bacteriol. 2004 Aug;186(16):5523-8.

2003

  1. Berres F, Resch G, Ruppert M, Meyer J, Kulik EM. Ribotyping Fusobacterium nucleatum isolates from healthy and diseased periodontiumSchweiz Monatsschr Zahnmed. 2003;113(9):953-7.

2002

  1. Resch G, Meyer J. Bacteriophages, a new perspective in the treatment of infectious diseases? Schweiz Monatsschr Zahnmed. 2002;112(6):643-5.

1999

  1. Louisy F, Tran CC, Resch G, Lemarquer-Domagala F, Finet M. Effect of upright tilt on venous hemodynamics in rat after three-week tail suspensionTrav Sci Cherch Serv Sante Armees. 1999;20:173-4.

1998

  1. Louisy F, Tran CC, Resch G, Luce P, Lemarquer F, Finet M. The venous tone is not altered after three-week tail suspension in ratsJ Gravit Physiol. 1998 Jul;5(1):P47-8.
  2. Tran CC, Louisy F, Resch G, Luce P, Lemarquer F, Finet M. Venous tone and repeated +Gz accelerationsJ Gravit Physiol. 1998 Jul;5(1):P35-6.